A randomized, placebo-controlled trial using a novel PAP delivery platform to treat patients with OSA and comorbid PTSD

ConclusionsAdherence to aPAP may be improved with the addition of SA and deserves further study. SA is as effective as standard aPAP for normalizing the AHI and improving sleep-related symptoms.Clinical trial registrationClinicalTrials.gov NCT02549508https://clinicaltrials.gov/ct2/show/NCT02549508?term=NCT02549508&rank=1“Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD”.
Source: Sleep and Breathing - Category: Respiratory Medicine Source Type: research